Mary Szela, Abbott
S
Mightier Than the Sword
When it comes to marketing, every syllable speaks volumes
Keeshia Muhammad, Teva Specialty Pharmaceuticals
Keeshia Muhammad
Eric Floyd, Cephalon
Andrin Oswald, Novartis
Kimberly Park, Vice President Sales and Marketing, PriCara, Ortho-McNeil Janssen Pharmaceuticals
Nancy Phelan, Wyeth
Christoph Westphal, Sirtris
Tightening the Chain
EU makes plans to police its supply chain
Kurt Graves, Vertex
Wendy Niebler, Shire
Perfectly Imperfect
Everyone makes mistakes; how you handle them is the measure of a true leader
Relaunching Reform
This time, powerful interest groups (like pharma) that sank the Clinton healthcare bill are on the side of change
James Galeota, Merck
Brett Villagrand, Genentech
Erik Harris, Elan
Hoji Alimi, Oculus Innovative Sciences
The Web Video (R)evolution
Pharma is taking note of online video's power to affect B2B communications
Adnan Mjalli, TransTech Pharma
Cameron Durrant, J&J
Roger Adsett, Shire
Dagmar Rosa-Bjorkeson, Novartis
Mark Stejbach, Merck
Mike Boken, Shire
Michael Burke, Ovation
Barry Greene, Alnylam
Malvinder Singh, Ranbaxy Labs
Sean McLoughlin, GlaxoSmithKline
Ludwig Hantson, Novartis
Everybody's Right
The great debate on DTC advertising is heating up again. We're going to be hearing a lot about fair balance and risk communication and costs. But what about the patients?
